Sinocare Asks Court To Rule Device Won't Infringe Abbott IP
Chinese medical device maker Sinocare has asked a London judge for a declaration that a modified version of its iCan glucose monitoring device doesn't infringe two Abbott patents, in the midst...To view the full article, register now.
Already a subscriber? Click here to view full article